Wood G S, Crooks C F, Uluer A Z
Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA.
J Invest Dermatol. 1995 Jul;105(1):51-5. doi: 10.1111/1523-1747.ep12312548.
Determination of the clonal relationship among multiple lymphoproliferative disorders occurring in individual patients has been hampered by dependence on molecular biologic techniques that require analysis of advanced lesions containing high tumor clone densities to isolate dominant, clonal antigen-receptor gene rearrangements. Polymerase chain reaction/denaturing gradient gel electrophoresis (PCR/DGGE) involves the amplification of T-cell receptor (TCR)-gamma gene rearrangements followed by their electrophoresis in denaturing gradient gels. This method detects dominant TCR-gamma gene rearrangements at tumor clone densities as low as 0.1%, making this assay suitable for analysis of early as well as late lesions. Using this approach, we analyzed skin lesions of lymphomatoid papulosis and either CD30+ large-cell lymphoma or early patch/plaque mycosis fungoides that developed in three patients. In each case, the dual specimens exhibited an identical band pattern by PCR/DGGE analysis, suggesting a common clonal origin. To confirm this clonal relationship, the dominant TCR-gamma gene rearrangements were eluted, amplified, cloned, and sequenced. In each case, they showed identical junctional sequences. These findings are significant for several reasons: 1) they demonstrate the common clonal origin of lymphomatoid papulosis and CD30+ large-cell lymphoma or mycosis fungoides occurring in individual patients; 2) they confirm that co-migrating PCR/DGGE bands exhibit identical nucleotide sequences; and 3) they provide a method for determining the sequence of a tumor-derived TCR-gamma gene rearrangement in early lesions containing a low tumor clone density. This latter feature should allow the prospective molecular staging of early cutaneous lymphoproliferative disorders.
确定个体患者中出现的多种淋巴增殖性疾病之间的克隆关系,一直受到依赖分子生物学技术的阻碍,这些技术需要分析含有高肿瘤克隆密度的晚期病变,以分离出显性的、克隆性抗原受体基因重排。聚合酶链反应/变性梯度凝胶电泳(PCR/DGGE)涉及T细胞受体(TCR)-γ基因重排的扩增,随后在变性梯度凝胶中进行电泳。该方法能检测低至0.1%的肿瘤克隆密度下的显性TCR-γ基因重排,使得该检测方法适用于早期和晚期病变的分析。利用这种方法,我们分析了3例患者发生的淋巴瘤样丘疹病和CD30+大细胞淋巴瘤或早期斑块/斑片型蕈样肉芽肿的皮肤病变。在每例中,通过PCR/DGGE分析,双份标本呈现相同的条带模式,提示有共同的克隆起源。为了证实这种克隆关系,将显性TCR-γ基因重排洗脱、扩增、克隆并测序。在每例中,它们显示出相同的连接序列。这些发现具有重要意义,原因如下:1)它们证明了个体患者中淋巴瘤样丘疹病和CD30+大细胞淋巴瘤或蕈样肉芽肿有共同的克隆起源;2)它们证实共迁移的PCR/DGGE条带具有相同的核苷酸序列;3)它们提供了一种在含有低肿瘤克隆密度的早期病变中确定肿瘤来源的TCR-γ基因重排序列的方法。后一特性应有助于早期皮肤淋巴增殖性疾病的前瞻性分子分期。